Main Menu

News

Industry news, press releases, and official statements from USIJ.
  • All News
  • Alliance News
  • Amicus Briefs
  • Comments & Letters
  • Industry News
  • Op-Eds
  • Statements & Releases
  • White Papers
All News
  • All News
  • Alliance News
  • Amicus Briefs
  • Comments & Letters
  • Industry News
  • Op-Eds
  • Statements & Releases
  • White Papers
USIJ Submits Comments in Response to USTR’s Request for Public Comments Regarding the 2026 Special 301 Review
January 29, 2026 Comments & Letters Industry News
USIJ Congratulates Executive Director Chris Israel on Receiving the 2026 Paul Michel Award
January 21, 2026 Alliance News
USIJ Releases 2025 Annual Report Highlighting Major Wins for American Innovators
January 21, 2026 Alliance News
USIJ Submits Comments to OSTP on Restoring America’s Innovation Ecosystem
January 12, 2026 Comments & Letters
USIJ Files Amicus Brief in Arbutus v. Moderna
January 5, 2026 Amicus Briefs
Chris Israel: Why Big Tech’s ‘Victim’ Narrative Doesn’t Hold Up
January 5, 2026 Op-Eds
USIJ Submits Comments to FTC–DOJ on Drug Pricing and Competition
December 19, 2025 Comments & Letters
USIJ Files Supreme Court Amicus Brief Defending Clear Limits on PTAB Jurisdiction
December 8, 2025 Amicus Briefs Industry News
USIJ Files Comments Supporting USPTO’s Proposed PTAB Reforms
December 8, 2025 Industry News
Ambassador Jeff Gerrish talks tariffs, pharmaceuticals, and foreign free-riding on the Wilkow Majority
November 25, 2025 Industry News

Sign up to receive news and updates from USIJ.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Name*
By signing up for the newsletter, you agree to the terms of use.
Scroll to Top